Literature DB >> 4251289

Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome.

D J Boullin, R A O'Brien.   

Abstract

1. Blood platelets from normal children and children with the trisomy 21 form of Down's syndrome (mongolism) were studied to determine the cause of the well established reduction in platelet 5-HT in the disease.2. Concentrations of endogenous 5-HT in the platelets from mongols were 25.3% of the concentrations found in normal children.3. The net accumulation of 5-HT in the mongol cells was decreased to 52.7% of normal. This reduction was probably due, in part, to a defect in 5-HT transport, because the initial rates of 5-HT uptake at plasma concentrations of 10(-6) and 10(-5)M were significantly slower.4. Experiments on the efflux of 5-HT from mongol platelets loaded with amine showed that the rate of loss was initially 2.6 and later 7.8 times faster than normal.5. Platelet ATP in mongol cells was 26% of normal, and the reduction of ATP and 5-HT was in the molar ratio of 3:1.6. It is considered that the low platelet 5-HT in Down's syndrome is due to a defective 5-HT transport mechanism and impaired 5-HT binding, resulting from a reduction in the essential binding substance, ATP.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4251289      PMCID: PMC1395660          DOI: 10.1113/jphysiol.1971.sp009325

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  The concentration of serotonin by platelets in Down's Syndrome.

Authors:  E E McCOoy; M J Rostafinsky; C Fishburn
Journal:  J Ment Defic Res       Date:  1968-03

2.  Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.

Authors:  M Bazelon; R S Paine; V A Coeiw; P Hunt; J C Houck; D Mahanand
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

Review 3.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Localization of 5-hydroxytryptamine in blood platelets: an autoradiographic and ultrastructural study.

Authors:  R B Davis; J G White
Journal:  Br J Haematol       Date:  1968-07       Impact factor: 6.998

5.  [Anomaly of serotonin fixation by blood platelets of trisomic 21 subjects. I. Study of the general characteristics of the fixation].

Authors:  H Jérome; P Kamoun
Journal:  Bull Soc Chim Biol (Paris)       Date:  1968

6.  Blood-serotonin deficiency in Down's syndrome.

Authors:  J B Tu; H Zellweger
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

7.  Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system.

Authors:  H Holmsen; I Holmsen; A Bernhardsen
Journal:  Anal Biochem       Date:  1966-12       Impact factor: 3.365

8.  Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.

Authors:  M Da Prada; A Pletscher
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

9.  Effect of thrombin on the radioactive nucleotides of human washed platelets.

Authors:  D M Ireland
Journal:  Biochem J       Date:  1967-11       Impact factor: 3.857

10.  The accumulation of guanethidine by human blood platelets.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

View more
  14 in total

1.  Adenosine triphosphate and diphosphoglycerate levels in red blood cells from patients with Down's syndrome.

Authors:  H R Knull; W W Bronstein; P J Porter
Journal:  Experientia       Date:  1978-09-15

2.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

3.  Uptake and loss of 14 C-dopamine by platelets from children with infantile autism.

Authors:  D J Boullin; R A O'Brien
Journal:  J Autism Child Schizophr       Date:  1972 Jan-Mar

4.  Laboratory predictions of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlation with the Rimland E-2 score.

Authors:  D J Boullin; M Coleman; R A O'Brien; B Rimland
Journal:  J Autism Child Schizophr       Date:  1971 Jan-Mar

5.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

6.  Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression.

Authors:  J Tuomisto; E Tukiainen; U G Ahlfors
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

7.  A common uptake system for serotonin and dopamine in human platelets.

Authors:  G S Omenn; L T Smith
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

8.  Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5-hydroxytryptamine.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

9.  Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.

Authors:  H J Weiss; T B Tschopp; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.

Authors:  P C Burger; F S Vogel
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.